SRPT - Sarepta Net earnings per share (EPS TTM)

Brandmark of Sarepta Therapeutics (SRPT)

Sarepta Therapeutics, Inc. (SRPT) business is insulated from market volatility, as demand for Duchenne muscular dystrophy treatment remains stable. The company relies on contract manufacturing organizations (CMO) for the production of complex RNA-based drugs. The trailing 12-month EPS demonstrates operational efficiency, where -1.38 shows the current value of the metric, while a validated cold-chain logistics network ensures the uninterrupted delivery of medications.

sarepta.com (SRPT) - Earnings per share for the trailing year from 07/04/2022 to 11/18/2026

Analytical breakdowns for Sarepta Therapeutics Inc (SRPT)

Basic company analysis:SRPT - Sarepta
Manufactured products of Sarepta Therapeutics

Sarepta Therapeutics, Inc. (SRPT) maintains a monopoly status in the muscular dystrophy DNA therapy segment, ensuring a steady revenue stream due to the uniqueness of its drugs. Analyzing this annual net income per share chart, an investor can see the rolling 12-month total income adjusted for the impact of share issuances, which allows for an objective assessment of the business's fundamental profitability and the determination of market growth potential or the risk of overheating.

Competing companies

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|RARE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics Inc)|Net earnings per share for the last four quarters Twist Bio (TWST)|TXG: Net earnings per share for the last 12 months|Earnings per share for the trailing year NTLA (Intellia Therapeutics)|Stoke Therapeutics (STOK) - Earnings per share for the last twelve months|BioLife Corp (BLFS) - Net earnings per share (EPS TTM)|WVE (wavelifesciences.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Maze Therapeutics Inc|Net earnings per share (EPS TTM) SION|PRME - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) TSHA (Taysha Corp)|Earnings per share for the trailing year QURE|MeiraGTx Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year REGENXBIO Corp (RGNX)|solidbio.com (SLDB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OCGN|PACB (PacBio Corp) - Net earnings per share (EPS TTM)|BNTC: Earnings per share for the trailing year|Earnings per share for the last twelve months Design Corp (DSGN)|Net earnings per share for the last 12 months Rocket Pharmaceuticals Inc RCKT|FDMT: Net earnings per one share for the last twelve months|LXEO: Earnings per share for the last 12 months|Korro Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Editas Medicine|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)